G. Martel‐Planche

发表

p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers.

C. Harris, M. Hollstein, M. Marion, 1994, Carcinogenesis.

Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia

R. Malekzadeh, P. Hainaut, F. Saidi, 2012, BMC Cancer.

Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia.

P. Hainaut, J. Scoazec, D. Maurici, 2001, The American journal of pathology.

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect

M. Olivier, P. Hainaut, S. Tavtigian, 2010, Human mutation.

p53 mutations in esophageal tumors from high‐incidence areas of China

M. Hollstein, R. Montesano, Shih-hsin Lu, 1995, International journal of cancer.

G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.

P. Hainaut, J. Mergny, V. Marcel, 2011, Carcinogenesis.

TP53 mutations and MDM2 gene amplification in squamous‐cell carcinomas of the esophagus in South Thailand

P. Hainaut, R. Montesano, A. Casson, 2000, International journal of cancer.

Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.

H. Bartsch, C. Drevon, R. Montesano, 1980, Mutation research.

Modulation of 06-Methylguanine-DNA Methyltransferase in Rat and Hamster Liver after Treatment with Dimethylnitrosamine1

R. Montesano, Christopher, J. Hall, 2006 .

Differential Repair of O 4 -Methylthymine and O 6 -Methylguanine in Rat and Hamster Liver

C. Wild, R. Montesano, H. Brésil, 1989 .

Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines.

P. Hainaut, R. Montesano, R. Holm, 1998, British Journal of Cancer.

Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas

M. Hollstein, P. Hainaut, R. Montesano, 1996, International journal of cancer.

Li‐Fraumeni and Li‐Fraumeni—like syndrome among children diagnosed with pediatric cancer in Southern Brazil

P. Hainaut, P. Ashton-Prolla, C. Rossi, 2013, Cancer.

TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child - evidence for chimerism involving a common mutant founder haplotype: case report

M. Olivier, P. Hainaut, F. Soares, 2011, BMC Cancer.

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.

M. Olivier, P. Hainaut, P. Ashton-Prolla, 2007, Cancer letters.

Age at cancer onset in germline TP53 mutation carriers: association with polymorphisms in predicted G-quadruplex structures.

Chang S. Chan, D. Cox, M. Olivier, 2014, Carcinogenesis.

TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

P. Hainaut, J. Saurin, J. Scoazec, 2001, British Journal of Cancer.

KRAS mutation status in primary nonsmall cell lung cancer and matched metastases

P. Hainaut, A. Italiano, F. Burel-Vandenbos, 2010, Cancer.

Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas.

I. Treilleux, R. Montesano, M. Vuillaume, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti‐EGFR treatment of a rare lung malignancy

A. Italiano, P. Hofman, V. Hofman, 2009, International journal of cancer.

Li-Fraumeni syndrome in a Malaysian kindred.

P. Hainaut, H. Ariffin, K. Ibrahim, 2008, Cancer genetics and cytogenetics.

Nonrandom distribution of O6-methylguanine in H-ras gene sequence from DNA modified with N-methyl-N-nitrosourea.

R. Montesano, F. Bleicher, N. Mironov, 1993, Mutation research.

TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis

M. Olivier, P. Hainaut, R. Brentani, 2009, Journal of Medical Genetics.

Inactivation of the p53 protein in cell lines derived from human esophageal cancers

Y. Furukawa, M. Hollstein, P. Hainaut, 1997, International journal of cancer.

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.

M. Olivier, P. Hainaut, V. Marcel, 2008, Cancer letters.

Detection in human cells of alkylated macromolecules attributable to exposure to nitrosamines.

C. Wild, R. Montesano, H. Brésil, 1988, IARC scientific publications.

WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus☆,☆☆

P. Hainaut, Rutao Cui, P. Tanière, 2005, Biochemical and Biophysical Research Communications - BBRC.

Modulation of O6-methylguanine-DNA methyltransferase in rat and hamster liver after treatment with dimethylnitrosamine.

C. Wild, R. Montesano, J. Hall, 1990, Cancer research.

Assay by inhibition of repair to measure O6‐methylguanine in DNA

C. Wild, N. Mironov, G. Martel‐Planche, 1994, Environmental and Molecular Mutagenesis.

Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil

P. Hainaut, M. Caleffi, P. Ashton-Prolla, 2014, PloS one.

Screening for p53 Gene Mutations in Archived Tumors of Workers Occupationally Exposed to Carcinogens: Examples from Analysis of Bladder Tumors

T. Sørlie, P. Vineis, M. Hollstein, 1995, Journal of occupational and environmental medicine.

Establishment and characterization of a spontaneously immortalized myofibroblast cell line derived from a human liver angiosarcoma.

M. Marion, A. Desmoulière, C. Trépo, 2000, Journal of hepatology.

Response to "Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome", by Ribeiro et al.

M. Olivier, P. Hainaut, P. Ashton-Prolla, 2007 .

Contribution of TP53 p.R337H mutation to breast cancer prevalence in Brazil

P. Hainaut, M. Caleffi, P. Ashton-Prolla, 2012 .

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti‐EGFR treatment of a rare lung malignancy

A. Italiano, P. Hofman, V. Hofman, 2009, International journal of cancer.

Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.

H. Bartsch, C. Drevon, R. Montesano, 1980, IARC scientific publications.

TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li–Fraumeni syndrome: impact on age at first diagnosis

M. Olivier, P. Ashton-Prolla, M. Achatz, 2009, Journal of Medical Genetics.

G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.

P. Hainaut, J. Mergny, V. Marcel, 2011, Carcinogenesis.